Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease
- PMID: 11580882
- DOI: 10.1007/s11906-001-0065-z
Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease
Abstract
Numerous prospective studies have shown that high heart rate is related to the development of hypertension, atherosclerosis, and incidence of cardiovascular events. Experimental studies in monkeys have shown that high heart rate has direct atherogenic effects on the arteries as a result of increased wall stress. However, clustering of several risk factors for coronary artery disease in persons with high heart rate suggests that sympathetic overactivity also accounts for part of the increased cardiovascular morbidity that is observed in persons with tachycardia. Indeed, experimental studies have shown that heightened sympathetic tone can cause obesity, hyperinsulinemia, and insulin resistance, which in the long term can promote the development of atherosclerosis. Through its interaction with plasma insulin, sympathetic overactivity can promote the development of left ventricular hypertrophy. Sympathetic activation can also increase hematocrit and precipitate a procoagulant state. Angiotensin II has an effect both on the central nervous system, enhancing sympathetic outflow, and on the peripheral sympathetic nerves. Among the angiotensin II receptor antagonists, eprosartan showed a particular ability to block presynaptic angiotensin II receptor 1 (AT(1)) receptors at neuro-effector junctions in the sympathetic nervous system, as well as AT(1) receptors in blood vessels. This dual action may represent an important advance in treatment of elevated blood pressure.
Similar articles
-
Relevance of heart rate as a risk factor in hypertension.Curr Hypertens Rep. 1999 Jun;1(3):219-24. doi: 10.1007/s11906-999-0024-7. Curr Hypertens Rep. 1999. PMID: 10981069 Review.
-
Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.Eur Heart J. 1998 Jun;19 Suppl F:F14-8. Eur Heart J. 1998. PMID: 9651730 Review.
-
Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.Curr Diabetes Rev. 2010 Mar;6(2):58-67. doi: 10.2174/157339910790909396. Curr Diabetes Rev. 2010. PMID: 20034369 Review.
-
Heart rate as a risk factor for atherosclerosis and cardiovascular mortality: the effect of antihypertensive drugs.Drugs. 1999 May;57(5):713-24. doi: 10.2165/00003495-199957050-00004. Drugs. 1999. PMID: 10353296 Review.
-
Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.J Hypertens Suppl. 1999 Jun;17(2):S27-32. J Hypertens Suppl. 1999. PMID: 10465064 Review.
Cited by
-
Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy.PLoS One. 2012;7(11):e48910. doi: 10.1371/journal.pone.0048910. Epub 2012 Nov 14. PLoS One. 2012. PMID: 23155428 Free PMC article.
-
Rab4a signaling unmasks a pivotal link between myocardial homeostasis and metabolic remodeling in the diabetic heart.J Mol Cell Cardiol. 2010 Dec;49(6):908-10. doi: 10.1016/j.yjmcc.2010.09.002. Epub 2010 Sep 16. J Mol Cell Cardiol. 2010. PMID: 20840849 Free PMC article. No abstract available.
-
Psychosocial factors and progression from prehypertension to hypertension or coronary heart disease.Ann Fam Med. 2007 Sep-Oct;5(5):403-11. doi: 10.1370/afm.738. Ann Fam Med. 2007. PMID: 17893381 Free PMC article.
-
Contribution of systemic vascular reactivity to variability in pulse volume amplitude response during reactive hyperemia.Eur J Appl Physiol. 2019 Mar;119(3):753-760. doi: 10.1007/s00421-018-04066-6. Epub 2019 Jan 14. Eur J Appl Physiol. 2019. PMID: 30637458
-
IL-1β and IL-18: inflammatory markers or mediators of hypertension?Br J Pharmacol. 2014 Dec;171(24):5589-602. doi: 10.1111/bph.12876. Br J Pharmacol. 2014. PMID: 25117218 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials